Synthgene Biotechnology Co.

BiotechnologySeries BWuxi, Chinasyngenebio.com

Latest round

Series B

Last raised

Mar 2025

Total raised

$47M

Investors

8

About Synthgene Biotechnology Co.

, Ltd. operates as a biotech company that focuses on the development of core materials for immunodiagnostic and in vitro diagnostic reagents and instruments. The core team members come from Nanjing University. The company has been selected as the Nanjing cultivates unicorn company. The products developed by the company can be categorized into eight parts, which are mRNA Raw Material, Sugars, GalNAc, Phosphonamidites, Nucleosides, Molecular Diagnostic, Succinates, and Phosphorus reagent. The specified products include Cap analogs, dNTPs, LNA, etc. The company generates revenue by developing nucleosides, nucleotides, diagnostic antigens, and antibodies.

Who invested in Synthgene Biotechnology Co.

8 investors across 3 rounds

See all investors in Synthgene Biotechnology Co.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Mar 27, 2025

    Amount

    Undisclosed

    Investors

    Locked

  2. Series A

    Apr 11, 2022

    Amount

    $47M

    Investors

    Locked

  3. Series A

    Jun 30, 2021

    Amount

    Undisclosed

    Investors

    Locked

Questions about Synthgene Biotechnology Co.

Who invested in Synthgene Biotechnology Co.?

Synthgene Biotechnology Co. has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Synthgene Biotechnology Co. raised?

Synthgene Biotechnology Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Synthgene Biotechnology Co. last raise money?

Synthgene Biotechnology Co.'s most recent round on record is a Series B, in Mar 2025.

What does Synthgene Biotechnology Co. do?

Synthgene Biotechnology Co. is a biotechnology company.

Where is Synthgene Biotechnology Co. headquartered?

Synthgene Biotechnology Co. is headquartered in Wuxi, China.

Which VCs invest in companies like Synthgene Biotechnology Co.?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Synthgene Biotechnology Co.'s stage. Their profiles are linked below.

Raising like Synthgene Biotechnology Co.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.